Weaver Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $828K | Sell |
10,593
-205
| -2% | -$16K | 0.2% | 106 |
|
|
2025
Q1 | $783K | Buy |
10,798
+110
| +1% | +$7.97K | 0.21% | 105 |
|
|
2024
Q4 | $791K | Buy |
10,688
+5,560
| +108% | +$412K | 0.22% | 107 |
|
|
2024
Q3 | $338K | Sell |
5,128
-5,525
| -52% | -$365K | 0.1% | 136 |
|
|
2024
Q2 | $984K | Sell |
10,653
-155
| -1% | -$14.3K | 0.32% | 83 |
|
|
2024
Q1 | $1.03M | Buy |
10,808
+2,890
| +36% | +$276K | 0.35% | 79 |
|
|
2023
Q4 | $604K | Buy |
+7,918
| New | +$604K | 0.24% | 89 |
|